STAAR Surgical is trading 10.5% down today at $25.79 after investors reacted negatively to its preliminary Q2 2026 net sales update.
- The company guided net sales to exceed $90 million, which is more than double the previous year's performance.
- The guidance was essentially in-line with the consensus estimate of $90.2 million, prompting a classic sell the news reaction.
- Shares have seen significant follow-through selling into regular trading hours following the announcement.